Eli Lilly and Company vs Morgan Stanley
Eli Lilly and Company is worth $1.061T, 3.2× the $336.227B market cap of Morgan Stanley. Updated daily.
| Metric | ||
|---|---|---|
| Market cap | $1.061T | $336.227B |
| Global rank | #1 | #2 |
| Share price | $1,189.41 | $214.08 |
| Change | -2.11% | -0.46% |
| Revenue | $65.179B | $65.966B |
| Net income | $20.640B | $16.861B |
| Country | United States | United States |
| Sector | Healthcare | Financial Services |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is Eli Lilly and Company bigger than Morgan Stanley?
- Eli Lilly and Company has a market cap of $1.061T against $336.227B for Morgan Stanley, making it 3.2 times as valuable.
- Which company earns more, LLY or MS?
- Eli Lilly and Company reported net income of $20.640B and Morgan Stanley reported $16.861B in their most recent annual periods.